Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.biofilgroup.net | |
Market Cap | 84.59 Cr. | |
Enterprise Value(EV) | 84.56 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.41 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 125.32 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.33 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 10.86 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 4.79 | Calculated using Price: 51.98 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 1.63 Cr. | 16,273,800 Shares |
FaceValue | 10 | |
About Biofil Chemicals & Pharmaceuticals Ltd. | ||
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops |
1 Day |
|
+0.37% |
1 Week |
|
-3.85% |
1 Month |
|
+5.07% |
3 Month |
|
+2.24% |
6 Month |
|
+14.85% |
1 Year |
|
-4.00% |
2 Year |
|
-15.60% |
5 Year |
|
+632.62% |
10 Year |
|
+2851.43% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 13.47 | 13.28 | 18.09 | 3.64 | 3.60 | 8.46 | 8.01 | 4.24 | 3.28 | |
Return on Capital Employed (%) | 12.97 | 14.04 | 21.86 | 5.13 | 5.06 | 10.12 | 12.18 | 6.23 | 4.76 | |
Return on Assets (%) | 4.14 | 4.13 | 7.81 | 2.05 | 1.99 | 3.63 | 3.28 | 2.69 | 2.24 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 8 | 11 | 13 | 13 | 14 | 15 | 16 | 17 | 17 | 18 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | |||||||
Curr. Liab. | 5 | 13 | 9 | 11 | 11 | 27 | 17 | 1 | 14 | 24 | |
Minority Int. | |||||||||||
Equity & Liab. | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 42 | |
Non Curr. Assets | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 9 | 9 | 9 | |
Curr. Assets | 5 | 15 | 13 | 15 | 14 | 32 | 23 | 9 | 22 | 33 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 14 | 24 | 22 | 24 | 24 | 42 | 33 | 19 | 31 | 42 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 6 | 13 | 13 | 12 | 23 | 30 | 36 | 22 | 30 | 35 | |
Other Income | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Total Income | 6 | 14 | 14 | 12 | 23 | 30 | 37 | 23 | 30 | 35 | |
Total Expenditure | -5 | -12 | -11 | -11 | -22 | -28 | -34 | -21 | -29 | -34 | |
PBIDT | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Fri, 10 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Pursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed copies of extract of Un-audited Financial Results for the quarter and half year ended 30th September 2023 published in newspapers i.e. Free Press Mumbai and Indore (In English) and Choutha Sansar (In Hindi) on 10th November 2023. You are requested to please take the same on record. |
Fri, 10 Nov 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Information regarding issue of "Letter of Confirmation" in lieu of Share Certificates. |
Thu, 09 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 09Th November 2023 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. With reference to the above captioned subject we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 03/2023-24) held on today i.e. Thursday 09th day of November 2023 has inter alia transacted following matters along with other routine businesses: 1. Approval of the Un-Audited Financial Results of the Company for the quarter as well as half year ended on 30th September 2023 along with Segment results Statement of assets and liabilities Cash Flow Statement and Limited Review Report (Copy of Unaudited financial Results for quarter as well as half year ended 30th September 2023 being submitted separately). |
Mon, 11 Dec 2023 |
|
|
|
|
|